We are thrilled to announce that our 1st anti-adhesion medical device, the SPORONGE Intranasal Splint, has received approval from Singapore’s Health Science Authority (HSA)! This ...

Sporogenics is now a member of co11ab. co11ab is a Singapore biomedtech incubator formed by Nanyang Technological University (NTU), A*STAR and National Health Group (NHG) ...

Sporogenics was featured on the latest issue on an online UK magazine, please click below link to read more about Sporogenics’s story and aspiration. https://ghp-news.com/issues/q1-2021/42/

Sporogenics is honored to be the recipient of JLabs Award at MedTech Innovator Asia Pacific 2020 Grand Final for 1 year residency at Johnson & ...

Please support us to join the quest to improve surgical outcomes by preventing postsurgical adhesion! https://medtechinnovator.org/medtech-innovator-asia-pacific-finalists-2020/

Check the website for details: https://www.apacmedvirtualforum.com

https://www.businesswire.com/news/home/20200713005698/en/MedTech-Innovator-Selects-20-Startups-Annual-Asia  

Among over 180 submissions, Sporogenics is delighted to be selected as one of the 40 medtech startups for an online pitch session on 26 May ...

Dec 2, 2019 Baxter International said Monday it plans to acquire Sanofi’s surgical products unit Seprafilm and related assets for $350 million in cash, confirming ...